Reps. Crenshaw and Trahan Lead Letter to FDA Regarding Authorization of New Monoclonal Antibodies and Antiviral Therapeutics
May 04, 2023
May 04, 2023
WASHINGTON, May 4 -- Rep. Dan Crenshaw, R-Texas, issued the following news release:
Congressman Dan Crenshaw (R-TX) and Congresswoman Lori Trahan (D-MA) are sending a letter to the Food and Drug Administration (FDA) requesting information on the agency's plan for authorizing new monoclonal antibodies and antiviral therapeutics.
The FDA recently deauthorized the last mAbs for COVID-19 and there is a lag in getting an updated version reauthorized. The letter to the a . . .
Congressman Dan Crenshaw (R-TX) and Congresswoman Lori Trahan (D-MA) are sending a letter to the Food and Drug Administration (FDA) requesting information on the agency's plan for authorizing new monoclonal antibodies and antiviral therapeutics.
The FDA recently deauthorized the last mAbs for COVID-19 and there is a lag in getting an updated version reauthorized. The letter to the a . . .